This resolution (HRES 691) commemorates the 135th anniversary of the 1890 Institutions - 19 historically Black land-grant universities established under the 1890 Morrill Act - to be observed on August 30, 2025. It recognizes these institutions’ 135 years of contributions to agricultural education, research, and extension, serving over 88,000 students in fields like STEM and agriculture. The resolution encourages federal and state ceremonies to celebrate their work and supports continued partnership with the USDA, though it does not create new funding or policy changes. It is a non-binding expression of congressional support for these institutions’ historical and ongoing mission.
S 2752 requires the U.S. President to conduct a 120-day review of U.S.-South Africa relations, prompted by Congress's findings that South Africa's government has consistently supported Hamas (a U.S. designated terrorist group), deepened ties with Russia (during its invasion of Ukraine), and strengthened partnerships with China (including CCP-linked institutions). The review must assess whether South Africa's actions undermine U.S. national security or foreign policy interests, leading to a certification. If the certification finds such actions, the bill mandates terminating South Africa's eligibility for key U.S. trade benefits under the African Growth and Opportunity Act (AGOA). The bill does not impose immediate sanctions but sets a process for potential trade consequences based on the review's findings.
HR 5278, the Affordable Inhalers and Nebulizers Act of 2025, limits out-of-pocket costs for patients using prescription inhalers and nebulizers to treat asthma and chronic obstructive pulmonary disease (COPD). The bill requires private health insurance plans, Medicare Part B and Part D, and new payment programs to cover these products with no deductible and a maximum cost of $15 per 30-day supply. It directly affects patients with asthma or COPD who rely on covered inhalers, nebulizers, and related equipment like spacers. The law applies to all specified inhaler products (including medications and administration equipment) and takes effect for plan years beginning January 1, 2026.
The SOAR Act Improvements Act (HR 5181) amends Washington, D.C.'s scholarship program to extend grant durations from 5 to 10 years without competitive renewal, expand eligibility to schools across the Washington metropolitan region (including parts of Maryland and Virginia), and update funding rules. It allows scholarship funds to cover pre-kindergarten, increases annual academic assistance funding from $2 million to $2.2 million, and requires participating schools to maintain accreditation. The bill also modifies evaluation requirements to include annual reporting on student outcomes like graduation rates and school safety comparisons, with evaluations mandated every seven years starting in 2027. These changes directly affect D.C. scholarship recipients, participating schools, and eligible entities administering the program.
The FIREARM Act (HR 3770) changes how federal firearm licensees (like dealers) handle violations of firearms laws. It requires the Attorney General to give licensees 30 business days to correct minor, self-reported violations - such as clerical errors - with assistance and training, instead of automatically revoking licenses. The bill also adds a 15-day window for licensees to challenge revocations in federal court, where courts must review the case anew and only uphold revocations if the licensee willfully violated the law. Additionally, it applies retroactively to licensees whose licenses were revoked under a 2021 enforcement policy, allowing them to reapply if they meet compliance requirements.
The RAISE Act of 2025 amends the Elementary and Secondary Education Act of 1965 to require states to establish academic standards for artificial intelligence and emerging technologies in K-12 education. It directly affects public K-12 schools and state education agencies by mandating the inclusion of AI-related learning standards within state curriculum frameworks. The key provision inserts the requirement for these standards into existing law, specifically modifying Section 1111(b)(1)(C) to include "standards for artificial intelligence and other emerging technologies." This policy change focuses on integrating AI education into foundational curriculum requirements without specifying funding or implementation details.
This bill prohibits the Environmental Protection Agency from reallocating renewable fuel requirements from small refineries that have extended exemptions under the Clean Air Act. It directly affects small refineries with extended exemptions and the companies that would otherwise cover their renewable fuel obligations. The key provision requires the EPA to include gasoline or diesel refined by these exempt small refineries in the total fuel volume calculation for the year, preventing other entities from bearing their share of the renewable fuel mandate. This changes how renewable fuel obligations are calculated to protect consumers from potential cost increases tied to reallocated requirements.
S 2744, the Federal Disaster Tax Relief Act of 2025, changes tax rules for individuals affected by qualifying disasters. It allows higher deductions for personal casualty losses from disasters declared after July 4, 2025, and before January 1, 2027, by increasing the deductible amount above 10% of adjusted gross income. The bill also creates a new tax exclusion for wildfire relief payments received between 2026 and 2030, excluding these payments from gross income while preventing double benefits for the same losses. These provisions directly affect individuals in federally declared disaster areas who incurred losses during specified periods.
HR 5226, the Deceptive Downsizing Prohibition Act of 2025, bans manufacturers from selling consumer products (like food) in smaller sizes using packaging designed for larger versions without clear disclosure. It directly affects manufacturers of consumer products by requiring them to prominently display both the previous larger size and current reduced size on the product packaging. The key mechanism is a "safe harbor" provision: manufacturers avoid penalties if they clearly show the size change on the main packaging panel with conspicuous, easy-to-understand text. The Federal Trade Commission (FTC) will enforce this as part of its authority over deceptive practices under existing law.
This resolution (SRES 376) symbolically recognizes suicide as a serious public health issue and designates September 8, 2025, as "988 Day" to honor the 988 Suicide and Crisis Lifeline. It does not create new programs but formally supports the national crisis line, which provides 24/7 mental health support via phone, chat, and text in over 150 languages. The resolution highlights the lifeline's role in connecting over 18 million people to crisis services since 2022 and cites statistics showing its effectiveness (98% of users found it helpful). It encourages public awareness of the service and broader efforts to expand mental health resources. The resolution directly affects the public by promoting recognition of the lifeline's importance in suicide prevention.
The Kidney Care Access Protection Act (S 2730) improves access to innovative treatments for patients with end-stage renal disease (ESRD) who require dialysis. The bill extends Medicare's Transitional Drug Add-On Payment Adjustment (TDAPA) period for new renal dialysis drugs approved after 2020 and creates a permanent post-TDAPA payment adjustment starting in 2026. It clarifies that Medicare payments will cover only drugs specifically for kidney disease treatment, not for related conditions like diabetes or heart disease. The legislation also requires Medicare Advantage plans to cover innovative kidney care therapies and adjusts payment calculations to better reflect actual costs for providers. These changes will take effect on January 1, 2026, for treatments provided after that date.
Sickle Cell Disease Comprehensive Care Act This bill allows state Medicaid programs to establish health homes to provide coordinated care for individuals with sickle-cell disease. (Under current law, state Medicaid programs may establish health homes to provide coordinated care for individuals with specified chronic conditions.) States must ensure that such care includes dental and vision services. The Centers for Medicare & Medicaid Services must issue best practices for states on how to design and implement such health homes.
